Re:The high-stakes race to engineer new psychedelic drugs
by debenedictis on Tuesday August 02, 2022 @06:44PM
(#32325232)
I too developed a rare health issue, OABSS.
"In our study, OABSS (overactive bladder symptom score) significantly increased with the combined use of ketamine and marijuana (P = 0.016). Cannabinoids are the active components of marijuana, and select cannabinoid receptors, CB1 and CB2, have been identified in the human detrusor and urothelium."
IMHE, it's not, at least in regards to (racemic) ketamine and depression. The benefit doesn't appear until ~24 hours later, and the effect scales with dosage, but not trip intensity or outcome.
I found taking it almost unpleasant at times, but the subsequent effects uniformly profound. Unfortunately, I developed a rare health issue, or I'd still be taking it.